Private Healthcare Growth in the Middle East: The Role of International Supply
Private healthcare across the Gulf and the wider Middle East has expanded rapidly, supported by investment in new hospitals, specialist clinics and medical tourism. With growth comes demand for reliable international supply of medicines and medical products.
What is driving demand
Large investment programmes in healthcare infrastructure.
Growing populations and rising rates of chronic disease.
Strong demand for aesthetics, wellness and specialist services.
Patients who travel to the UK for treatment and want continuity of care at home.
What buyers in the region value
Products from well-regulated markets, with full traceability.
Suppliers who understand local registration and import requirements.
Reliable logistics, especially for temperature-sensitive products in a hot climate.
Responsive communication across time zones and languages.
The UK advantage
UK-sourced medicines carry the assurance of MHRA regulation and Good Distribution Practice. For clinics and distributors in the region, a UK partner can be a valuable part of a diversified supply strategy.
Working with Acorn
Acorn Pharmaceuticals welcomes enquiries from clinics, chemists and distributors across the Middle East. Our international procurement page is available in Arabic, and we will guide you through what can be supplied to your country.
Talk to Acorn Pharmaceuticals: email gb@acornpharmaceuticals.co.uk or message us on WhatsApp.
Comments